Raspa

Raspa is a biopharmaceutical company that is committed to making treatment for cancer and other severe diseases more affordable, accessible, and sustainable. Most drugs for cancer and other severe diseases are very expensive despite being off-patent- making these drugs unaffordable for a majority of patients. We are developing novel processes to enhance manufacturing efficiencies and reduce the production costs of the building blocks of these drugs. We are confident that our value-based innovation and patient-centric approach will help us realize our vision of ensuring the availability of affordable, quality healthcare to every patient

Raspa operates in the Pharmaceutical manufacturing industry.

Raspa's revenue is 11m - 100m

Raspa has 11 - 50 employees.